Conditions

Search for a condition by name and view related trials.

Myocardial Infarction

Related Clinical Trials

Title	Acronym	Phase
Vitamin Therapy for Prevention of Stroke		3
Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin	PEGASUS	3
Stroke and MI in Users of Estrogen/Progestogen		N/A
Trial to Assess the Effects of SCH 530348 in Preventing Heart Attack and Stroke in Patients With Acute Coronary Syndrome (TRA•CER) (Study P04736AM3)		3
Postmenopausal Progestins, MI and Stroke		N/A
Stroke Risk in the NAS-NRC Twin Registry		N/A
Subclinical Thyroid Dysfunction and Risk of Myocardial Infarction and Stroke		N/A
Molecular Epidemiology of Myocardial Infarction and Stroke in Older Adults - Ancillary to CHS		N/A
HOPE-2 Study (Heart Outcomes Prevention Evaluation-2 Study)		4
Using AtorVASTatin to Prevent VAscular Inflammatory OccLUSion in the Critically Ill	VASTVALUS	2/ 3
The Effect Of Acadesine On Reducing Cardiovascular and Cerebrovascular Adverse Events In Coronary Artery Bypass Graft (CABG) Surgery (Study P05633 AM1)(TERMINATED)	RED-CABG	3
Remote Ischemic Preconditioning in High Risk Cardiovascular Surgery Patients		3
Periodontitis and Cardiovascular Events or "PAVE"		N/A
Safety, Pharmacokinetic and -Dynamic Study of PR-15, an Inhibitor of Platelet Adhesion	PR-15/01	1
NORVIT and WENBIT - Long-term Follow-up	NORVIT-WENBIT	N/A
Analyzing Gene Regions That May Interact With the Effectiveness of High Blood Pressure Drugs		N/A
Look AHEAD: Action for Health in Diabetes	Look AHEAD	N/A
Early Detection of Arteriosclerosis		N/A
The Effect of GLP-1 on Glucose Uptake in the Brain and Heart in Healthy Men		N/A
The Effect of GLP-1 on Glucose Uptake in the Brain and Heart in Healthy Men During Hypoglycemia		N/A
Multi-Ethnic Study of Atherosclerosis (MESA)		N/A
Safety and Effectiveness of Two Blood Transfusion Strategies in Surgical Patients With Cardiovascular Disease	FOCUS	3
Antihypertensive Drug/Gene Interactions and CV Events		N/A
Pharmacogenetics and Cardiovascular Events		N/A
Hormone Replacement Therapy and Prothrombotic Variants		N/A
Honolulu Heart Program		N/A
Homocyst(e)Ine, Vitamin Status, and CVD Risk		N/A
Nurses' Health Study		N/A
Sleep Heart Health Study (SHHS) Data Coordinating Center	SHHS	N/A
Inflammation, Infection, and Future Cardiovascular Risk		N/A
Health Professionals Follow-up Study		N/A
Carotid Atherosclerosis Follow-Up Study		N/A
Antiplatelet Therapy Continuation in Spine Surgery - Its Effect on Postoperative Morbidity and Mortality		N/A
Imaging Modalities in Detection of Coronary Artery Disease in End-Stage Renal Disease Patients		N/A
Improving Intermediate Risk Management. MARK Study	MARK	N/A
Prothrombin Times Outside the Therapeutic Range in Otherwise Stable Patients	FORESPEAK-0	2
Epidemiology of Aeromedical Evacuation		N/A
Serum Adiponectin in Chinese Population and Its Correlation to Cardiovascular and Cerebrovascular Diseases		N/A
Flavonoids and Cardiovascular Disease		N/A
Mortality Follow-Up and Analyses of Men in the MRFIT		N/A
Evans County Studies		N/A
Trial to Assess the Ocular Safety of SCH 530348 in Patients With Atherosclerosis (Study P05183AM1)(COMPLETED)		3
Epidemiology of Insulin Growth Factor (IGF) and Cardiovascular Events		N/A
Stanford Five-City Multifactor Risk Reduction Study		N/A
Minnesota Heart Survey - Risk Factor Survey		N/A
Infection and Cardiovascular Disease		N/A
Minnesota Heart Health Program		N/A
Predictors of Cardiovascular Disease in the Elderly		N/A
Salt Sensitivity, Cardiovascular and Metabolic Disease		N/A
Investigation of Genetic Risk of Cardiovascular Disease in Prospective Cohort Study		N/A
Observational Aspirin Use and CVD in the Physicians' Health Study		N/A
Plaque Inflammation and Dysfunctional HDL Cholesterol in Participants Receiving Niacin and Statins in the AIM-HIGH Study (The HDL Proteomics Study)	HDL Proteomics	N/A
A 30 Day Study to Evaluate Efficacy and Safety of Pre-hospital vs. In-hospital Initiation of Ticagrelor Therapy in STEMI Patients Planned for Percutaneous Coronary Intervention (PCI)	ATLANTIC	4
Troponin-T for Detection of Perioperative Cardiovascular Events	VISION-pilot	N/A
Prevention of Cardiovascular Complications in Diabetic Patients With Vitamin E Treatment		2/ 3
Carotid Revascularization Endarterectomy Versus Stenting Trial	CREST	3
Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial	WARCEF	3
Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)		3
Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1)	COGENT-1	3
Insulin Resistance Intervention After Stroke Trial	IRIS	3
Niacin Plus Statin to Prevent Vascular Events		3
Vascular Events In Noncardiac Surgery Patients Cohort Evaluation Study (VISION)	VISION	N/A
WENBIT - Western Norway B Vitamin Intervention Trial	WENBIT	3
IMPROVE-IT: Examining Outcomes in Subjects With Acute Coronary Syndrome: Vytorin (Ezetimibe/Simvastatin) vs Simvastatin (P04103 AM5)		3
The Post Stroke Preventive Trial (PREVENT). A RCT Nested in a Cohort Study	PREVENT	N/A
Trial to Assess the Effects of SCH 530348 in Preventing Heart Attack and Stroke in Patients With Atherosclerosis (TRA 2°P - TIMI 50) (Study P04737AM3)		3
WEUSKOP5410: Observational Study in ENABLE Clinical Trials		N/A
Implementation of a Personalized Medicine (Pharmacogenomics) Service in a Community Pharmacy		1
Anglo-Scandinavian Cardiac Outcomes Trial: Post Trial Follow-Up Study	ASCOT-10	N/A
Natural History of Carotid Atherosclerosis		N/A
Platelet Reactivity and MES During CEA		N/A
Aspirin Versus Aspirin + ClopidogRel Following Transcatheter Aortic Valve Implantation: the ARTE Trial	ARTE	4
Association of Endothelial Function and Clinical Outcomes in Subjects Admitted to Chest Pain Unit		N/A
Renin-angiotensin-aldosterone System Polymorphisms in Resistant Hypertension and Adverse Cardiovascular Events	GENHART	N/A
Vascular Events In Surgery patIents cOhort evaluatioN - Cardiac Surgery		N/A